| Entry |
|
|---|
| Name |
Nartograstim (genetical recombination) (JAN);
Nartograstim (INN) |
|---|
| Formula |
C850H1344N226O245S8
|
|---|
| Exact mass |
18893.7422
|
|---|
| Mol weight |
18905.67
|
|---|
| Sequence |
MAPTYRASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
QMEELGMAPA LQPTQGAMPA FASAFQRRAG GVLVASHLQS FLEVSYRVLR HLAQP
(Disulfide bridge: 37-43, 65-75) |
|---|
| Type |
Peptide |
|---|
| Class |
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
|
|---|
| Efficacy |
Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF) |
|---|
| Comment |
recombinant Granulocyte colony stimulating factor (G-CSF) [HSA: 1440] [KO: K05423]
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01781 Granulocyte colony stimulating factor (G-CSF)
D03245 Nartograstim
Target-based classification of drugs [BR:br08310]
Signaling molecules and receptors
Cytokine receptors
CSF and other factor receptors
CSF3R (GCSFR, CD114)
D03245 Nartograstim (genetical recombination) (JAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
